Criminalization of drug use

Criminalization of drug use in Dopesick is not simply a matter of arresting people who possess or sell drugs; it is a governing framework that defines addiction as a criminal-justice problem rather than a public-health problem. The book follows its uneven consequences through the opioid crisis: medical systems helped widen access to prescription opioids, while policing and imprisonment fell especially heavily on people of color and on sellers whose circumstances were treated differently from those of many white opioid users. Against this punitive cycle, it considers treatment, practical reentry support, and harm reduction as ways to address both addiction and the conditions that sustain drug markets.

From health problem to crime problem

The book locates the turn toward criminalization in the political choices of the 1970s, when the United States chose to address drug addiction and dependence through crime control rather than health care. That choice drew force from fear and anger, and made punishment a durable public response to drug use. The War on Drugs thus appears not as a neutral intervention applied equally to everyone, but as a policy whose institutions and effects must be examined alongside the social conditions of addiction.

The account sets this punitive framework beside a contrasting expansion in medical treatment. When OxyContin was introduced in 1996, physicians, hospitals, and accreditation bodies were adopting pain as the fifth vital sign. The Joint Commission on Accreditation of Healthcare Organizations made pain-assessment and treatment standards mandatory in 1999. As hospitals competed over patient satisfaction and reimbursement, the demand to take pain seriously created pressure for more liberal treatment. Purdue Pharma presented OxyContin as safe for a broad range of pain and promoted a claimed addiction risk of less than one percent; the company also planned materials to help hospitals meet the new standards. The book does not equate prescribing with criminalization. Instead, it places the expansion of medical opioid supply beside the punitive treatment of people caught in addiction, showing how institutions could widen exposure to opioids while leaving later users to face a justice system organized around punishment.

The new measures of pain also carried an important limitation. Pain scales made assessment easier to standardize, but the apparent precision concealed the subjective judgments beneath the numbers. The book notes that the scales did not reliably correspond to better patient outcomes and were associated with increased opioid prescribing and abuse. This history complicates a simple contrast between responsible medicine and irresponsible drug use: clinical standards and commercial promotion helped shape the environment in which opioid dependence spread, even as addiction was commonly treated as an individual offense.

Unequal enforcement and unequal protection

Roanoke’s earlier understanding of heroin illustrates how drug use could be made visible or invisible through social assumptions. In the 1980s and 1990s, heroin was widely regarded as an inner-city drug, associated with a small, largely African American group that police and court reporters knew about. Don Wolthuis, a federal prosecutor, described users as an isolated population who withdrew from public view rather than committing the kinds of visible crimes associated with crack or methamphetamine. The prevailing belief among some Black users and dealers that heroin should not be sold to white people further reflects how race shaped the perceived boundaries of the market. Later, as heroin spread among white suburban users, the public framing changed, but the criminal-justice response did not change equally for everyone.

The book makes that disparity explicit through Ronnie Jones’s imprisonment for armed heroin distribution. He was serving a third prison term in a system that, the account argues, offered limited routes back into ordinary life: a felony record could impede access to mainstream employment, while drug-involved offenders faced high rates of reoffending. The discussion cites a five-year recidivism rate of 75 percent for drug traffickers released from prison. In this context, repeated imprisonment is not presented as proof that punishment has solved addiction or drug dealing; it is part of a cycle in which release can return people to joblessness and renewed contact with the justice system.

The contrast with white opioid users is particularly sharp. Public-health and police officials often acknowledged that arrest alone could not resolve the epidemic, especially when discussing mostly white users who dealt drugs or committed property crimes to avoid withdrawal. The book argues that this language of treatment and diversion was less readily extended to people such as Jones or to other Black and brown people arrested for selling drugs. It reports that three-quarters of federal drug offenders were Black or Hispanic and that people of color made up 57 percent of state-imprisoned drug offenders. The cited analysis also found that white people used drugs at comparable rates and were more likely to sell them, while Black people were more likely to be arrested for drug possession or sales.

Medical treatment was unequal as well as enforcement. The book cites 2014 data showing that doctors prescribed painkillers to people of color at substantially lower rates than to white patients, in part because clinicians distrusted people of color to use opioids responsibly. The resulting disparity complicates any account that treats race as a simple predictor of drug exposure: unequal prescribing could limit some groups’ access to medications, while drug policing and prosecution continued to impose disproportionate burdens on them. Medical judgment and criminal enforcement therefore operated as distinct institutions with different consequences, but both were shaped by racialized assumptions.

The costs of punishment and the gaps in care

The concept also reaches beyond the prison sentence itself. Families struggling with addiction encountered shame, secrecy, and weak connections between health care and criminal justice. In 2012, there were not yet statewide Facebook groups through which parents could share information about rehabilitation or support one another. At a Families Anonymous meeting outside Hidden Valley, two mothers of addicted young men met; their experiences brought into view the gaps between the two institutions expected to respond to the crisis. In those gaps, families and volunteers tried to keep loved ones alive, while people with addiction struggled to survive and avoid withdrawal. Criminalization could make the justice system a point of contact without ensuring a reliable transition into treatment.

The book’s comparison of release systems shows why that distinction matters. A reentry plan centered on housing, case management, employment, and harm reduction could help former dealers find legitimate work while reducing the economic need for drug dealing. Bryan Stevenson’s Equal Justice Initiative sent clients to cities such as Seattle, where diversion programs could direct low-level offenders with addiction away from prosecution and toward services. Such a model treats public safety and access to care as connected rather than opposing aims. It also addresses a practical cause of recidivism: a person leaving prison may need housing and employment, not merely a warning against returning to crime.

Alternatives and the book’s argument

The book presents Virginia’s first drug court, launched in Winchester, as a local example of a different approach. It connected offenders with treatment, including medication-assisted treatment, and offered access to free housing and taxi vouchers to help participants get to work. In a rural region where transportation could obstruct employment and care, those supports addressed barriers that imprisonment alone could not remove. The program did not erase the broader punitive system, but it demonstrated that a court could direct resources toward treatment and stability rather than relying only on confinement.

Portugal provides a wider comparison. After it decriminalized all drugs, drug-related health problems, including sexually transmitted diseases and deaths associated with drug use, declined, according to sources discussed in the book. The account emphasizes that the shift toward a health-centered response and the increased availability of treatment were central to the reported improvements; decriminalization also allowed resources to move from criminal justice toward care. The comparison is not presented as a single policy that automatically resolves addiction, but as evidence that the consequences of drug use depend partly on how institutions respond.

By placing corporate promotion, clinical standards, racial disparities, imprisonment, and treatment access in the same narrative, Dopesick challenges the assumption that criminalization is a sufficient answer to addiction. Its central contrast is between a system that repeatedly arrests people within conditions conducive to relapse and approaches that connect them to treatment, housing, and work. The book’s account suggests that drug policy cannot be evaluated by arrests alone: it must also be judged by who receives medical care, who is punished, and whether people leaving the justice system have a practicable path back into community life.